Marta Toledano-Fonseca
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 03, 2026
<i>NR3C1</i>, <i>LAX1</i>, and <i>RCAN3</i> as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer.Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano-Osuna
|Aug 01, 2025
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients.Marta Toledano-Fonseca, María Teresa Cano-Osuna, Elena Élez
|Jun 10, 2025
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.Carmen Navarrete-Sirvent, Ana Mantrana, Aurora Rivas-Crespo
|Jul 09, 2022
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab.M José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna
|Apr 03, 2021
The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.Marta Toledano-Fonseca, M Teresa Cano, Elizabeth Inga
|Jul 08, 2020
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer.Marta Toledano-Fonseca, M Teresa Cano, Elizabeth Inga
Pageof 2
Frequent Collaborators
6 joint publications
Antonio Rodríguez-Ariza
4 joint publications
Silvia Guil-Luna
3 joint publications
Enrique Aranda
2 joint publications
Rafael Mena-Osuna
2 joint publications
María Victoria García-Ortiz
1 joint publications
Laura M López-Sánchez
1 joint publications
Rafael Jiménez-Izquierdo
1 joint publications
Jon Peñarando
1 joint publications
Francisco Conde
1 joint publications
Ignacio Ortea
